Gilead Sciences, Inc. et al v. JAMP Pharma Corporation
2022
T-1484-22
Pending
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,845,553 (tenofovir alafenamide).
Counsel to:
JAMP Pharma Corporation
The decision is reported
here.